55 North Private Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$283K Buy
541
+54
+11% +$27.6K 0.05% 205
2026
Q2
$242K Buy
487
+18
+4% +$7.98K 0.05% 228
2026
Q1
$209K Buy
+469
New +$219K 0.05% 199

Other funds holding VRTX

55 North Private Wealth's VRTX Position: Q3 2026 in Review

55 North Private Wealth increased its Vertex Pharmaceuticals (VRTX) stake by 11% in Q3 2026, buying an estimated $27.6K and bringing the position to 541 shares worth $283K. The position accounts for 0.05% of the portfolio, ranked #205.

55 North Private Wealth first reported a position in VRTX in Q1 2026 and has held it in 3 quarters since. 1,793 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • 55 North Private Wealth held 541 shares of Vertex Pharmaceuticals worth $283K as of Q3 2026.
  • 55 North Private Wealth bought 54 Vertex Pharmaceuticals shares in Q3 2026, an estimated $27.6K.
  • Vertex Pharmaceuticals made up 0.05% of 55 North Private Wealth's portfolio in Q3 2026, its #205 holding.
  • 55 North Private Wealth first reported a position in Vertex Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • 1,793 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on 55 North Private Wealth's 13F filing for Q3 2026, filed 20 Oct 2026.